Anika Therapeutics | ANIK - Pre Tax Profit


Anika Therapeutics reported $764K in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Abbott USD 2.36B 178M Dec/2025
Agenus USD -10.61M 263.52M Dec/2025
Agios Pharmaceuticals USD -109.06M 5.62M Dec/2025
Anika Therapeutics USD 764K 3M Dec/2025
Arrowhead Research USD 28.27M 7.85M Dec/2025
Enanta Pharmaceuticals USD -22.71M 95.08M Dec/2024
Halozyme Therapeutics USD 218.96M 14.02M Sep/2025
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Insmed USD -326.93M 41.77M Dec/2025
Integra LifeSciences USD -6.82M 524.13M Sep/2025
Intrexon USD -60.48M 27.09M Jun/2024
J&J USD 4.97B 2.53B Dec/2025
Karyopharm Therapeutics USD -39.9M 9.01M Dec/2025
Ligand Pharmaceuticals USD 141.14M 102M Sep/2025
MacroGenics USD -14.93M 31.75M Dec/2025
Merit Medical Systems USD 73.18M 29.8M Sep/2025
Rigel Pharmaceuticals USD -1.03M 7.22M Jun/2024
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sanofi EUR -1.16B 5.5B Dec/2025
Smith & Nephew USD 469M 70M Dec/2025
Stryker USD 1.03B 13M Sep/2025
Surmodics USD -5.9M 1.61M Jun/2025
Veracyte USD 40.63M 21.74M Dec/2025
Xencor USD -4.27M 1.76M Dec/2025
Zimmer Biomet Holdings USD 418.7M 194.1M Sep/2025